DaVita (NYSE:DVA) Given New $169.00 Price Target at Barclays

DaVita (NYSE:DVA) had its price objective boosted by Barclays from $164.00 to $169.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has an equal weight rating on the stock.

DaVita Stock Performance

NYSE:DVA opened at $154.98 on Tuesday. The company has a market capitalization of $12.71 billion, a PE ratio of 16.72, a P/E/G ratio of 0.84 and a beta of 0.94. The company has a 50 day simple moving average of $161.41 and a two-hundred day simple moving average of $157.91. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. DaVita has a fifty-two week low of $119.42 and a fifty-two week high of $179.60.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 88.18% and a net margin of 6.53%. Research analysts anticipate that DaVita will post 9.71 earnings per share for the current year.

Hedge Funds Weigh In On DaVita

Institutional investors and hedge funds have recently modified their holdings of the business. Franklin Resources Inc. lifted its holdings in shares of DaVita by 134.6% in the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock worth $8,885,000 after purchasing an additional 31,502 shares in the last quarter. FMR LLC lifted its holdings in shares of DaVita by 659.9% in the 3rd quarter. FMR LLC now owns 177,406 shares of the company’s stock worth $29,082,000 after purchasing an additional 154,061 shares in the last quarter. Atom Investors LP bought a new position in shares of DaVita in the 3rd quarter worth $4,094,000. Assenagon Asset Management S.A. lifted its holdings in shares of DaVita by 201.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock worth $11,159,000 after purchasing an additional 49,885 shares in the last quarter. Finally, Neo Ivy Capital Management bought a new position in shares of DaVita in the 3rd quarter worth $726,000. 90.12% of the stock is currently owned by institutional investors.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.